20.500.12556/RUL-186566 Advanced drug delivery systems for topical treatment of common skin diseases a decade in review Common skin diseases including fungal skin infections, atopic dermatitis, acne vulgaris, and psoriasis represent a substantial health burden and remain therapeutically challenging. Creams, ointments, gels and other conventional topical formulations are constrained by drug instability, uncontrolled drug release, inadequate skin penetration, and the need for frequent application, which compromise their therapeutic effectiveness and reduce patient adherence. Advanced topical drug delivery systems have emerged as promising strategies to overcome these limitations. This paper provides a disease-driven overview of the most recent advancements in topical treatment of the selected common skin diseases over the past decade. Using a systematic approach, we highlight innovations across micro- and nanoemulsions, vesicular systems, lyotropic liquid crystals, liquid crystalline nanoparticles, lipid nanoparticles, polymeric nanoparticles, and nanofibers, emphasising how they address critical therapeutic challenges. Each disease is examined in terms of its pathophysiology, unmet therapeutic needs, and the formulation strategies most frequently investigated for its treatment. Drug delivery platforms are organised by their prevalence in the literature, enabling cross-disease comparison and illustrating how formulation advances translate into patient benefits. Ultimately, we aim to highlight recent progress in this field and outline directions for future research, thereby supporting the development of next-generation topical therapies for common skin diseases. topical drug delivery skin penetration controlled release nanomedicine formulation design lokalna uporaba zdravil penetracija skozi kožo nadzorovano sproščanje nanomedicina zasnova formulacije dostavni sistemi koža true false true Angleški jezik Slovenski jezik Članek v reviji 2026-09-03 07:51:36 2026-09-03 07:51:42 2026-09-04 04:30:43 0000-00-00 00:00:00 2026 0 0 20 str. art. 127348 Vol. 703 Oct. 2026 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 615.015.14:616.5 1873-3476 10.1016/j.ijpharm.2026.127348 289533187 1-s2.0-S0378517326007969-main.pdf 1-s2.0-S0378517326007969-main.pdf 1 C8E0BCBDB9D622503B7FC689ACB131BC 46fd0460fae2eb55a6bcb2f2885ab67c5de4f95919873a12e638f82eec31266d 70741fb8-a75b-11f1-9b0d-0050569b8976 https://repozitorij.uni-lj.si/Dokument.php?lang=slv&id=245840 https://www.sciencedirect.com/science/article/pii/S0378517326007969 1 1cb76e66-a75b-11f1-9b0d-0050569b8976 https://repozitorij.uni-lj.si/Dokument.php?lang=slv&id=245839 Fakulteta za farmacijo 0 0 0